Announcement of the resolution of the first holder meeting of the 2024 employee shareholding plan.
Material for the first interim shareholder meeting in 2024.
Announcement regarding the top ten shareholders and the top ten shareholders with unlimited sales conditions, on the matter of repurchasing stocks.
Announcement on the Progress of Establishing a Wholly-Owned Subsidiary for Foreign Investment
Announcement regarding the completion of industrial and commercial change registration and issuance of business license.
Announcement Regarding the Revision of the Company's Articles of Association
Announcement on establishing wholly-owned subsidiary for overseas investment and carrying out grassroots medical services business.
Notice of the First Extraordinary Shareholders' Meeting in 2024
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinions of Beijing Deheng (Kunming) Law Firm on the 2023 Annual General Meeting of Shareholders of Jianzhijia Pharmaceutical Chain Group Co., Ltd.
2023 Annual General Meeting of Shareholders Meeting Materials
Jianzhijia Pharmaceutical Chain Group Co., Ltd. 2023 Internal Control Evaluation Report
Report of the Audit Committee of Jianzhijia Pharmaceutical Chain Group Co., Ltd. on the performance of supervisory duties by accounting firms in 2023
Jianzhijia Pharmaceutical Chain Group Co., Ltd. report on the performance of Xinyong Zhonghe Certified Public Accountants (Special General Partnership)
Notice on Using Idle Own Funds for Cash Management
2024 Employee Stock Ownership Plan (Draft)
Summary of Jianzhijia Pharmaceutical Chain Group Co., Ltd. 2024 Employee Stock Ownership Plan (Draft)
Notice on amending the “Articles of Association”
Notice on convening the 2023 Annual General Meeting of Shareholders of the Company
Announcement on the acquisition of assets related to the wholly-owned subsidiary of Sichuan Derentang Pharmaceutical Chain Co., Ltd.
No Data